US Patent Issued to Iterion Therapeutics on May 13 for "Crystalline form of tegavivint, method of preparation, and use thereof" (California, Texas Inventors)

ALEXANDRIA, Va., June 12 -- United States Patent no. 12,297,185, issued on May 13, was assigned to Iterion Therapeutics Inc. (Houston).

"Crystalline form of tegavivint, method of preparation, and use thereof" was invented by Drazen Ostovic (Redwood City, Calif.) and Gowri Sukumar (Spring, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to crystalline forms of (9E,10E)-2,7-bis((3,5-dimethylpiperidin-1-yl)sulfonyl)anthracene-9,10-dione dioxime, pharmaceutical compositions comprising the crystalline form, processes for preparing the crystalline form and methods of use therefore."

The patent was filed on Sept. 29, 2021, under Application No. 17/489,684.

*For further informati...